Interestingly, a recent study reported a greater exposure to crizotinib and its active metabolite PF-06260182 in subjects with severe renal impairment (creatinine clearance 25%) were increased AST/ALT, lymphopenia, increased ALP, hypocalcemia, neutropenia, thrombocytopenia, hypophosphatemia, and hyperbilirubinemia
~ AlphaMD I woke up one morning three months into daily injections, looked at my perfectly stable testosterone levels on paper, and realized I felt absolutely nothing
------------------------------------------------------------------------- Amanda Lovett-Jones is an Australian Naturopath, registered Herbalist, and culinary medicine specialist
Abstract 14387: dose-related reductions in blood pressure with a RNA interference (RNAi) therapeutic targeting angiotensinogen in hypertensive patients: interim results from a first-in-human phase 1 study of ALN-AGT01